Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 5 d e
Lee H et al. (2020)
|
Xla Wt + chrd.1 MO
NF11 (in situ hybridization)
|
|
|
|
Fig. S 6 c d
Lee H et al. (2020)
|
Xla Wt + chrd.1 MO
NF11 (in situ hybridization)
|
|
|
|
Fig. 5 f g
Lee H et al. (2020)
|
Xla Wt + chrd.1 MO
NF32 (in situ hybridization)
|
|
|
|
Fig. S 2 c d
Lee H et al. (2020)
|
Xtr Wt + chrd.1 CRISPR
NF11 (in situ hybridization)
|
|
|
|
Fig. S 4 c d
Lee H et al. (2020)
|
Xtr Wt + rspo2 CRISPR + chrd.1 CRISPR
NF11 (in situ hybridization)
|
|
|
|
fig.8
Rankin SA et al. (2011)
|
Xla Wt + chrd MO + nog MO
NF11 (in situ hybridization)
|
|
|